Search
for
Sort by
Research 961–990 of 1000+
- Molecular Mechanisms Regulating Hair Follicle Development
- Cell death by cornification
- Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications
- Wound Healing and Skin Regeneration
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Epidermal Notch signalling: differentiation, cancer and adhesion
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Dermal β-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation
- Food Bioactive Compounds and Emerging Techniques for Their Extraction: Polyphenols as a Case Study
- Histopathology of alopecia: a clinicopathological approach to diagnosis
- Zinc Therapy in Dermatology: A Review
- Fibroblast growth factors: key players in regeneration and tissue repair
- Skin Pigmentation Types, Causes and Treatment—A Review
- Corticotropin releasing hormone and the skin
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling
- Efficacy of topical sensitizers in the treatment of alopecia areata
- New Antifungal Agents and New Formulations Against Dermatophytes
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- A keratin scaffold regulates epidermal barrier formation, mitochondrial lipid composition, and activity
- Control of hair follicle cell fate by underlying mesenchyme through a CSL–Wnt5a–FoxN1 regulatory axis
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Interleukin-1 Induces Transcription of Keratin K6 in Human Epidermal Keratinocytes
- Keratins and disease at a glance
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/– mice
- JAK Inhibitors for Treatment of Alopecia Areata
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases